A Murine Model for Metastatic Conjunctival Melanoma

被引:17
作者
de Waard, Nadine E. [1 ,2 ]
Cao, Jinfeng [2 ,3 ]
McGuire, Sean P. [1 ]
Kolovou, Paraskevi E. [1 ]
Jordanova, Ekaterina S. [4 ]
Ksander, Bruce R. [1 ]
Jager, Martine J. [1 ,2 ]
机构
[1] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Boston, MA USA
[2] Leiden Univ, Med Ctr, Dept Ophthalmol, NL-2300 RC Leiden, Netherlands
[3] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun 130023, Peoples R China
[4] Vrije Univ Amsterdam Med Ctr, Dept Obstet & Gynaecol, Ctr Gynaecol Oncol, Amsterdam, Netherlands
关键词
conjunctiva; melanoma; metastatic; mouse model; HUMAN PROSTATE-CANCER; SKIN CARCINOMA-CELLS; MELANOCYTIC LESIONS; MALIGNANT-MELANOMA; TUMOR PROGRESSION; UVEAL MELANOMA; NRAS MUTATIONS; BRAF MUTATIONS; MOUSE MODELS; ANIMAL-MODEL;
D O I
10.1167/iovs.14-15239
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Conjunctival melanoma (CM) is an ocular malignancy with a high rate of local recurrences after treatment, and can give rise to deadly metastases. The establishment of a murine model will further our understanding of this disease and allow in vivo testing of new therapies. We therefore analyzed the ability of three CM cell lines to grow orthotopically and spread to distant sites. Furthermore, we determined the characteristics of the xenografts and their metastases. METHODS. Orthotopic xenografts of human CM were established by subconjunctival injection of three different CM cell lines into NOD/SCID IL2 r gamma(null) mice. Single-cell suspensions were generated from the primary tumors and placed subconjunctivally in another set of mice, which were then screened for metastases. The presence of melanoma markers was determined on the cell lines and during tumor development. RESULTS. Subconjunctival injection of cultured CM cells into immunodeficient mice led to excellent subconjunctival tumor growth in all inoculated mice (n = 101) within 2 weeks; however, no metastases were found at the time of autopsy. Serial in vivo passage of primary tumor cells resulted in metastatic tumors in the draining lymph nodes (n = 21). The CM cell lines, as well as the tumor xenografts and their metastases, were positive for the melanoma markers HMB-45, S100B, and MART-1. Two cell lines and their corresponding xenografts carried a BRAF mutation, the third showed an NRAS mutation. CONCLUSIONS. We established a murine model for CM that shows excellent formation of metastases in a pattern that accurately resembles metastatic human CM following in vivo passaging.
引用
收藏
页码:2325 / 2333
页数:9
相关论文
共 45 条
[1]   Immunotherapy for Melanoma: Current Status and Perspectives [J].
Alexandrescu, Doru T. ;
Ichim, Thomas E. ;
Riordan, Neil H. ;
Marincola, Francesco M. ;
Di Nardo, Anna ;
Kabigting, Filamer D. ;
Dasanu, Constantin A. .
JOURNAL OF IMMUNOTHERAPY, 2010, 33 (06) :570-590
[2]  
Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005
[3]   Match criteria for human cell line authentication: Where do we draw the line? [J].
Capes-Davis, Amanda ;
Reid, Yvonne A. ;
Kline, Margaret C. ;
Storts, Douglas R. ;
Strauss, Ethan ;
Dirks, Wilhelm G. ;
Drexler, Hans G. ;
MacLeod, Roderick A. F. ;
Sykes, Gregory ;
Kohara, Arihiro ;
Nakamura, Yukio ;
Elmore, Eugene ;
Nims, Raymond W. ;
Alston-Roberts, Christine ;
Barallon, Rita ;
Los, Georgyi V. ;
Nardone, Roland M. ;
Price, Paul J. ;
Steuer, Anton ;
Thomson, Jim ;
Masters, John R. W. ;
Kerrigan, Liz .
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (11) :2510-2519
[4]   Management of conjunctival melanoma [J].
Damato, Bertil ;
Coupland, Sarah E. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (09) :1227-1239
[5]   Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging [J].
Damato, Bertil ;
Coupland, Sarah E. .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 36 (08) :786-795
[6]  
Eagle R.C., 2011, EYE PATHOLOGY ATLAS
[7]   Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma [J].
Errington, J. A. ;
Conway, R. M. ;
Walsh-Conway, N. ;
Browning, J. ;
Freyer, C. ;
Cebon, J. ;
Madigan, M. C. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (03) :451-458
[8]   Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma [J].
Flaherty, Keith T. ;
Robert, Caroline ;
Hersey, Peter ;
Nathan, Paul ;
Garbe, Claus ;
Milhem, Mohammed ;
Demidov, Lev V. ;
Hassel, Jessica C. ;
Rutkowski, Piotr ;
Mohr, Peter ;
Dummer, Reinhard ;
Trefzer, Uwe ;
Larkin, James M. G. ;
Utikal, Jochen ;
Dreno, Brigitte ;
Nyakas, Marta ;
Middleton, Mark R. ;
Becker, Juergen C. ;
Casey, Michelle ;
Sherman, Laurie J. ;
Wu, Frank S. ;
Ouellet, Daniele ;
Martin, Anne-Marie ;
Patel, Kiran ;
Schadendorf, Dirk .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) :107-114
[9]   Inhibition of Mutated, Activated BRAF in Metastatic Melanoma [J].
Flaherty, Keith T. ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
O'Dwyer, Peter J. ;
Lee, Richard J. ;
Grippo, Joseph F. ;
Nolop, Keith ;
Chapman, Paul B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) :809-819
[10]  
FOLBERG R, 1989, OPHTHALMOLOGY, V96, P1006